Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UBE2V1 pseudogene 12 (UBE2V1P12) is a non-coding pseudogene located in the human genome. Unlike the functional UBE2V1 gene—which encodes a ubiquitin-conjugating enzyme variant involved in ubiquitination, DNA repair, NF-kappa-B signaling, and immune response—UBE2V1P12 does not produce any functional protein and is not involved in cellular processes, disease mechanisms, or therapeutic interactions[5][6]. The presence of pseudogenes like UBE2V1P12 is common in the genome and may occasionally serve as genomic regulatory elements, but this is not known or established for UBE2V1P12. Key points: - UBE2V1P12 should not be confused with UBE2V1, the active ubiquitin-conjugating enzyme E2 variant 1[3][5]. - UBE2V1P12 is not a receptor, enzyme, transporter, or other classical drug target class. - There is no evidence for drug interactions, disease involvement, or biomarker status for UBE2V1P12[5]. - Therapeutic targeting, mechanism of action, and safety concerns do not apply to this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin conjugating enzyme E2 V1 pseudogene 12 (UBE2V1P12).